Bioequivalence of zonisamide orally dispersible tablet and immediate-release capsule formulations: results from two open-label, randomized-sequence, single-dose, two-period, two-treatment crossover studies in healthy male volunteers.
Phase of Trial: Phase I
Latest Information Update: 03 Sep 2009
At a glance
- Drugs Zonisamide (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors Eisai Co Ltd
- 03 Sep 2009 New trial record.
- 01 Jun 2009 Results published in Clinical Therapeutics.